Case study of CD19 CAR T therapy in a subject with immune-mediate necrotizing myopathy treated in the RESET-Myositis phase I/II trial.
Volkov J, Nunez D, Mozaffar T, Stadanlick J, Werner M, Vorndran Z, Ellis A, Williams J, Cicarelli J, Lam Q, Furmanak T, Schmitt C, Hadi-Nezhad F, Thompson D, Miller C, Little C, Chang D, Basu S.
Volkov J, et al. Among authors: nunez d.
Mol Ther. 2024 Nov 6;32(11):3821-3828. doi: 10.1016/j.ymthe.2024.09.009. Epub 2024 Sep 7.
Mol Ther. 2024.
PMID: 39245937
Free PMC article.
Clinical Trial.